Treatment persistence to tolvaptan in patients with autosomal dominant polycystic kidney disease: a secondary use of data analysis of patients in the IMADJIN® dataset

Overview of attention for article published in BMC Nephrology, December 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 10,721 followers.

RT @ASPNeph: Treatment persistence to #tolvaptan in patients with autosomal dominant polycystic kidney disease: a secondary use of data ana…

RT @ASPNeph: Treatment persistence to #tolvaptan in patients with autosomal dominant polycystic kidney disease: a secondary use of data ana…

RT @ASPNeph: Treatment persistence to #tolvaptan in patients with autosomal dominant polycystic kidney disease: a secondary use of data ana…

Treatment persistence to #tolvaptan in patients with autosomal dominant polycystic kidney disease: a secondary use of data analysis of patients in the #IMADJIN® dataset. #ADPKD @BioMedCentral https://t.co/TSSuYbD8Ih

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.